The Preventive Efficacy of ULP for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery
NCT07923968, Not applicable, Not yet recruiting, Peking University People's Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Preventive Efficacy of ULP for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery | ClinicalTrials.gov |
| NCT number | NCT07923968 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 236 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Peking University People's Hospital | ClinicalTrials.gov |
| Conditions | Stress Urinary Incontinence in Women, Pelvic Organ Prolapse (POP) | ClinicalTrials.gov |
| Interventions | pubourethral ligament plication | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | The incidence of overt stress urinary incontinence at 3 months postoperatively between the two groups. | 3 months after surgery | Overt stress urinary incontinence is defined as meeting any one of the following criteria: 1. The difference between the 3-month postoperative ICIQ-SF total score and the preoperative ICIQ-SF total score is ≥ 4 points, and ICIQ-SF question 6 identifies leakage mainly during coughing, sneezing, physical activity or exercise; 2. Positive cough stress test. | ClinicalTrials.gov |
| Secondary | Incidence of urinary retention at 3 days after surgery between the two groups. | 3 days after surgery | Urinary retention is defined as post-void residual urine volume \> 100 mL after catheter removal, or requirement for reinsertion of urinary catheter. | ClinicalTrials.gov |
| Secondary | Difference in lower urinary tract symptoms at 3 months after surgery between the two groups. | 3 months after surgery | Lower urinary tract symptoms will be assessed using the Overactive Bladder Symptom Score (OABSS).The score of OABSS ranges from 0 to 15. The higher the score, the more severe the lower urinary tract symptoms are. | ClinicalTrials.gov |
| Secondary | Difference in patient satisfaction at 3 months after surgery between the two groups | 3 months after surgery | Patient satisfaction will be evaluated using the Patient Global Impression of Improvement (PGI-I) questionnaire.The score of PGI-I ranges from 0 to 7. The higher the score, the lower the patient's satisfaction is. | ClinicalTrials.gov |
| Secondary | The incidence of overt stress urinary incontinence at 6 months postoperatively between the two groups. | 6 months after surgery | Overt stress urinary incontinence is defined as meeting any one of the following criteria: 1. The difference between the 6-month postoperative ICIQ-SF total score and the preoperative ICIQ-SF total score is ≥ 4 points, and ICIQ-SF question 6 identifies leakage mainly during coughing, sneezing, physical activity or exercise; 2. Positive cough stress test. | ClinicalTrials.gov |
| Secondary | The incidence of overt stress urinary incontinence at 1 year postoperatively between the two groups. | 1 year after surgery | Overt stress urinary incontinence is defined as meeting any one of the following criteria: 1. The difference between the 1-year postoperative ICIQ-SF total score and the preoperative ICIQ-SF total score is ≥ 4 points, and ICIQ-SF question 6 identifies leakage mainly during coughing, sneezing, physical activity or exercise; 2. Positive cough stress test. | ClinicalTrials.gov |
| Secondary | Difference in POP-Q point Aa at 1 year after surgery between the two groups | 1 year after surgery | The Pelvic Organ Prolapse Quantification system (POP-Q) will be measured and compared between groups at 1 year after surgery. | ClinicalTrials.gov |
| Other | Incidence of adverse events and complications up to 1 year after surgery | Up to 1 year after surgery | All adverse events and procedure-related complications occurring from the perioperative period up to 1 year after surgery will be recorded, and their incidence will be compared between the two groups. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)